6-K Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 Q2 2020

Filing Information

Form Type	6-K
Accession Number	`0001213900-20-024100`
Period End Date	20200630
Filing Date	20200828
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	clgn-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 60 Cash Flow Statement 68 Stockholders Equity 26

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in NIS)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Ordinary shares, par value (in NIS)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	5.67M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.79M	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	6.47M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.67M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	5.67M	shares	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	6.47M	shares	Point-in-time
Trade receivables	`ReceivablesNetCurrent`	$79.00K	USD	Point-in-time
Trade receivables	`ReceivablesNetCurrent`	$321.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$270.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$750.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$12.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$12.00K	USD	Point-in-time
Inventory	`InventoryNet`	$730.00K	USD	Point-in-time
Inventory	`InventoryNet`	$888.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.49M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.04M	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$167.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$168.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$3.05M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$3.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.33M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.25M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$5.71M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$5.46M	USD	Point-in-time
Total assets	`Assets`	$10.95M	USD	Point-in-time
Total assets	`Assets`	$10.75M	USD	Point-in-time
Loan	`LoansPayableCurrent`	$12.00K	USD	Point-in-time
Loan	`LoansPayableCurrent`	$24.00K	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$833.00K	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$559.00K	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.20M	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$866.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$455.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$442.00K	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$942.00K	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$297.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.18M	USD	Point-in-time
Derivatives	`DerivativeLiabilitiesNoncurrent`	$42.00K	USD	Point-in-time
Derivatives	`DerivativeLiabilitiesNoncurrent`	$68.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.95M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$3.14M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$3.00M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$3.21M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.17M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2020 and December 31, 2019; issued and outstanding: 6,467,536 and 5,670,829 ordinary shares as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$2.37M	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2020 and December 31, 2019; issued and outstanding: 6,467,536 and 5,670,829 ordinary shares as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$2.71M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidInCapitalAndWarrants`	$74.86M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidInCapitalAndWarrants`	$69.95M	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-67.26M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$5.78M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.72M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$7.27M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$764.00K	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.09M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$5.42M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$10.95M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$10.75M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Revenue from product sales	`CostFromSaleOfGoods`	$-606.00K	USD	1 Quarter
Revenue from product sales	`CostFromSaleOfGoods`	$-1.23M	USD	2 Qtrs
Revenue from product sales	`CostFromSaleOfGoods`	$-713.00K	USD	1 Quarter
Revenue from product sales	`CostFromSaleOfGoods`	$-1.05M	USD	2 Qtrs
Revenue from service	`CostOfServicesSold`	$-110.00K	USD	1 Quarter
Revenue from service	`CostOfServicesSold`	-	USD	1 Quarter
Revenue from service	`CostOfServicesSold`	$-152.00K	USD	2 Qtrs
Revenue from service	`CostOfServicesSold`	$-204.00K	USD	2 Qtrs
Total Revenue	`Revenues`	$606.00K	USD	1 Quarter
Total Revenue	`Revenues`	$1.43M	USD	2 Qtrs
Total Revenue	`Revenues`	$823.00K	USD	1 Quarter
Total Revenue	`Revenues`	$1.20M	USD	2 Qtrs
Cost of Revenue	`CostOfRevenue`	$883.00K	USD	2 Qtrs
Cost of Revenue	`CostOfRevenue`	$463.00K	USD	1 Quarter
Cost of Revenue	`CostOfRevenue`	$748.00K	USD	1 Quarter
Cost of Revenue	`CostOfRevenue`	$1.22M	USD	2 Qtrs
Gross Profit	`GrossProfit`	$75.00K	USD	1 Quarter
Gross Profit	`GrossProfit`	$209.00K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$317.00K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$143.00K	USD	1 Quarter
Research and development, net	`ResearchAndDevelopmentExpense`	$1.86M	USD	2 Qtrs
Research and development, net	`ResearchAndDevelopmentExpense`	$1.81M	USD	2 Qtrs
Research and development, net	`ResearchAndDevelopmentExpense`	$1.08M	USD	1 Quarter
Research and development, net	`ResearchAndDevelopmentExpense`	$1.00M	USD	1 Quarter
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$2.02M	USD	2 Qtrs
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$1.75M	USD	2 Qtrs
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$986.00K	USD	1 Quarter
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$820.00K	USD	1 Quarter
Total operating loss	`OperatingIncomeLoss`	$-1.76M	USD	1 Quarter
Total operating loss	`OperatingIncomeLoss`	$-3.29M	USD	2 Qtrs
Total operating loss	`OperatingIncomeLoss`	$-3.62M	USD	2 Qtrs
Total operating loss	`OperatingIncomeLoss`	$-1.91M	USD	1 Quarter
Financial income	`FinancialIncome`	$48.00K	USD	2 Qtrs
Financial income	`FinancialIncome`	$26.00K	USD	2 Qtrs
Financial income	`FinancialIncome`	$630.00K	USD	1 Quarter
Financial income	`FinancialIncome`	$9.00K	USD	1 Quarter
Financial expenses	`FinancialExpenses`	$6.00K	USD	1 Quarter
Financial expenses	`FinancialExpenses`	$6.00K	USD	2 Qtrs
Financial expenses	`FinancialExpenses`	$6.00K	USD	2 Qtrs
Financial expenses	`FinancialExpenses`	$2.00K	USD	1 Quarter
Exchange differences	`ForeignCurrencyTransactionGainLossBeforeTax`	$28.00K	USD	2 Qtrs
Exchange differences	`ForeignCurrencyTransactionGainLossBeforeTax`	$-242.00K	USD	2 Qtrs
Exchange differences	`ForeignCurrencyTransactionGainLossBeforeTax`	$-65.00K	USD	1 Quarter
Exchange differences	`ForeignCurrencyTransactionGainLossBeforeTax`	$-111.00K	USD	1 Quarter
Financial income (expenses), net	`FinancialExpensesNet`	$48.00K	USD	2 Qtrs
Financial income (expenses), net	`FinancialExpensesNet`	$-58.00K	USD	1 Quarter
Financial income (expenses), net	`FinancialExpensesNet`	$-200.00K	USD	2 Qtrs
Financial income (expenses), net	`FinancialExpensesNet`	$513.00K	USD	1 Quarter
Loss for the period	`NetIncomeLoss`	$-3.49M	USD	2 Qtrs
Loss for the period	`NetIncomeLoss`	$-1.25M	USD	1 Quarter
Loss for the period	`NetIncomeLoss`	$-3.57M	USD	2 Qtrs
Loss for the period	`NetIncomeLoss`	$-1.97M	USD	1 Quarter
Basic and diluted loss per ordinary share	`EarningsPerShareBasicAndDiluted`	$0.52	USD	2 Qtrs
Basic and diluted loss per ordinary share	`EarningsPerShareBasicAndDiluted`	$0.28	USD	1 Quarter
Basic and diluted loss per ordinary share	`EarningsPerShareBasicAndDiluted`	$0.27	USD	1 Quarter
Basic and diluted loss per ordinary share	`EarningsPerShareBasicAndDiluted`	$0.75	USD	2 Qtrs
Weighted average ordinary shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.66M	shares	1 Quarter
Weighted average ordinary shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.66M	shares	2 Qtrs
Weighted average ordinary shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.81M	shares	2 Qtrs
Weighted average ordinary shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.96M	shares	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net cash used in operations (see Appendix A)	`NetCashProvidedByUsedInOperations`	$-4.34M	USD	2 Qtrs
Net cash used in operations (see Appendix A)	`NetCashProvidedByUsedInOperations`	$-2.73M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.73M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.34M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.06M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$246.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.06M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-246.00K	USD	2 Qtrs
Proceeds from issuance of shares, net	`ProceedsFromIssuanceOrSaleOfEquity`	$4.40M	USD	2 Qtrs
Proceeds from issuance of shares, net	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	2 Qtrs
Exercise of options into shares	`ProceedsFromOptionsExercises`	$7.00K	USD	2 Qtrs
Exercise of options into shares	`ProceedsFromOptionsExercises`	$67.00K	USD	2 Qtrs
Loan paid	`RepaymentsOfDebt`	$8.00K	USD	2 Qtrs
Loan paid	`RepaymentsOfDebt`	$12.00K	USD	2 Qtrs
Payments made for equipment on financing terms	`PaymentsMadeForEquipmentOnFinancingTerms`	-	USD	2 Qtrs
Payments made for equipment on financing terms	`PaymentsMadeForEquipmentOnFinancingTerms`	$17.00K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-18.00K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.46M	USD	2 Qtrs
Decrease in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-134.00K	USD	2 Qtrs
Decrease in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-3.80M	USD	2 Qtrs
Cash and cash equivalents and restricted deposits at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.97M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.85M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.66M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.91M	USD	Point-in-time
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$54.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.00K	USD	2 Qtrs
Cash and cash equivalents and restricted deposits at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.97M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.85M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.66M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.91M	USD	Point-in-time
Loss	`NetIncomeLoss1`	$3.49M	USD	2 Qtrs
Loss	`NetIncomeLoss1`	$3.57M	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$228.00K	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$327.00K	USD	2 Qtrs
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$289.00K	USD	1 Quarter
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$477.00K	USD	1 Quarter
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$794.00K	USD	2 Qtrs
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$629.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`ExchangeDifferencesOnCashAndCashEquivalents`	$14.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`ExchangeDifferencesOnCashAndCashEquivalents`	$54.00K	USD	2 Qtrs
Financial expenses related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$-26.00K	USD	2 Qtrs
Financial expenses related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$60.00K	USD	2 Qtrs
Net change of operating lease accounts	`NetChangeOfOperatingLeaseAccounts`	$32.00K	USD	2 Qtrs
Net change of operating lease accounts	`NetChangeOfOperatingLeaseAccounts`	$-292.00K	USD	2 Qtrs
Adjustments, noncash items, to reconcile net income (loss) to cash provided by (used in) operating activities	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-2.33M	USD	2 Qtrs
Adjustments, noncash items, to reconcile net income (loss) to cash provided by (used in) operating activities	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-2.52M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInInterestsContinuedToBeHeldByTransferorCurrent`	$242.00K	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInInterestsContinuedToBeHeldByTransferorCurrent`	$95.00K	USD	2 Qtrs
Decrease (increase) in inventory	`IncreaseDecreaseInInventories`	$144.00K	USD	2 Qtrs
Decrease (increase) in inventory	`IncreaseDecreaseInInventories`	$-158.00K	USD	2 Qtrs
Decrease (increase) in other receivables (including long-term receivables)	`IncreaseDecreaseInOtherReceivables`	$-11.00K	USD	2 Qtrs
Decrease (increase) in other receivables (including long-term receivables)	`IncreaseDecreaseInOtherReceivables`	$480.00K	USD	2 Qtrs
Increase (decrease) in trade payables (including long-term payables)	`IncreaseDecreaseInAccountsPayableTrade`	$-274.00K	USD	2 Qtrs
Increase (decrease) in trade payables (including long-term payables)	`IncreaseDecreaseInAccountsPayableTrade`	$156.00K	USD	2 Qtrs
Increase (decrease) in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-337.00K	USD	2 Qtrs
Increase (decrease) in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$91.00K	USD	2 Qtrs
Decrease in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredRevenue`	$-411.00K	USD	2 Qtrs
Decrease in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredRevenue`	$-645.00K	USD	2 Qtrs
Increase (Decrease) in Operating Capital	`IncreaseDecreaseInOperatingCapital`	$392.00K	USD	2 Qtrs
Increase (Decrease) in Operating Capital	`IncreaseDecreaseInOperatingCapital`	$1.82M	USD	2 Qtrs
Net cash used in operations	`AdjustmentForNetCashProvidedByUsedInOperations`	$-4.34M	USD	2 Qtrs
Net cash used in operations	`AdjustmentForNetCashProvidedByUsedInOperations`	$-2.73M	USD	2 Qtrs
Conversion of pre-paid warrants to ordinary shares	`ConversionOfStockAmountConverted1`	-	USD	2 Qtrs
Conversion of pre-paid warrants to ordinary shares	`ConversionOfStockAmountConverted1`	$137.00K	USD	2 Qtrs
Obtaining right of use assets in exchange for a lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Obtaining right of use assets in exchange for a lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$23.00K	USD	2 Qtrs
Classification of warrants from equity to liabilities, net	`ProceedsFromIssuanceOfWarrants`	$1.80M	USD	2 Qtrs
Classification of warrants from equity to liabilities, net	`ProceedsFromIssuanceOfWarrants`	-	USD	2 Qtrs

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares and warrants	`IssuanceOfOrdinarySharesAndWarrants`	$50.00K	USD	2 Qtrs
BALANCE	`StockholdersEquity`	$5.78M	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.72M	USD	Point-in-time
BALANCE	`StockholdersEquity`	$7.27M	USD	Point-in-time
BALANCE	`StockholdersEquity`	$764.00K	USD	Point-in-time
BALANCE	`StockholdersEquity`	$4.09M	USD	Point-in-time
BALANCE	`StockholdersEquity`	$5.42M	USD	Point-in-time
Classification of warrants from equity to liability	`ClassificationOfWarrantsFromEquityToLiability`	$-1.80M	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$67.00K	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.00K	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$477.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$794.00K	USD	2 Qtrs
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$289.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.49M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.97M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.57M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.25M	USD	1 Quarter
Issuance of ordinary shares and warrants, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$4.40M	USD	2 Qtrs
BALANCE	`StockholdersEquity`	$5.78M	USD	Point-in-time
BALANCE	`StockholdersEquity`	$1.72M	USD	Point-in-time
BALANCE	`StockholdersEquity`	$7.27M	USD	Point-in-time
BALANCE	`StockholdersEquity`	$764.00K	USD	Point-in-time
BALANCE	`StockholdersEquity`	$4.09M	USD	Point-in-time
BALANCE	`StockholdersEquity`	$5.42M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.